e-PKGene: A knowledge-based research tool for analysing the impact of genetics on drug exposure
暂无分享,去创建一个
Casey Lynnette Overby | Isabelle Ragueneau-Majlessi | Catherine K Yeung | Houda Hachad | Sophie Argon | René H Levy | C. Yeung | H. Hachad | C. L. Overby | R. Levy | I. Ragueneau-Majlessi | S. Argon | C. Overby
[1] E. Hatano,et al. Impact of regulatory polymorphisms in organic anion transporter genes in the human liver , 2009, Pharmacogenetics and genomics.
[2] A. Bhathena,et al. Pharmacogenetics: improving drug and dose selection. , 2008, Current opinion in pharmacology.
[3] M. Khoury,et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? , 2007, Genetics in Medicine.
[4] Janet Woodcock,et al. Pharmacogenetics--tailoring treatment for the outliers. , 2009, The New England journal of medicine.
[5] Guilherme Del Fiol,et al. Developing a Prototype System for Integrating Pharmacogenomics Findings into Clinical Practice , 2012, Journal of personalized medicine.
[6] Juan P. Casas,et al. Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies , 2009, PloS one.
[7] Table of Valid Genomic Biomarkers in the Context of Approved Drug Labels , 2009 .
[8] David A. Katz,et al. Defining drug disposition determinants: a pharmacogenetic–pharmacokinetic strategy , 2008, Nature Reviews Drug Discovery.
[9] A. Daly,et al. Genome-wide association studies in pharmacogenomics , 2010, Nature Reviews Genetics.
[10] G. Wilkinson,et al. Drug metabolism and variability among patients in drug response. , 2005, The New England journal of medicine.
[11] M. Khoury. Dealing With the Evidence Dilemma in Genomics and Personalized Medicine , 2010, Clinical pharmacology and therapeutics.
[12] P. Deverka. Pharmacogenomics, Evidence, and the Role of Payers , 2009, Public Health Genomics.
[13] J. Woodcock,et al. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective , 2004, Nature Reviews Drug Discovery.